Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary 

# AGENCY:

Department of Defense, Assistant Secretary of Defense (Health Affairs). 

# ACTION:

Notice of meeting.

# SUMMARY:

This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. 

# DATES:

Friday, December 16, 2005, from 8 a.m. to 4 p.m. 

# ADDRESSES:

Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. 

# FOR FURTHER INFORMATION CONTACT:

                        Mr. Rich Martel, TRICARE Management Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone (703) 681-0064 ext. 3672, fax (703) 681-1242,or e-mail at                         *richard.martel.ctr@tma.osd.mil.*

# SUPPLEMENTARY INFORMATION:

                    The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DoD Pharmacy and Therapeutics (P&T) Committee coming out of that body's meeting in November 2005. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at                     *http://pec.ha.osd.mil.*                     Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to                     *richard.martel.ctr@tma.osd.mil*                     no later than December 9, 2005. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes.                 

Dated: October 26, 2005. 

L.M. Bynum, 

Alternate OSD Federal Register Liaison Officer, DoD. 

[FR Doc. 05-21780 Filed 11-1-05; 8:45 am] 

BILLING CODE 5001-06-M